ARCHIVES

FDA Didn’t Punish Duke for Failing To Seek Proper Regulatory Clearance for Three Trials

This article is from The Cancer Letter archive.

Vol. 38 No. 04 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

Nebraska Legislature Revives Eppley With New Cigarette Tax

June 25, 1981

Sunitinib Prolongs Survival In Poor Prognosis, Study Finds

July 31, 2009

Committee Recommends FDA Approval Of Three New Drugs For Cancer Treatment

March 27, 1998

High Response Rate of Hairy Cell Leukemia Patients to Immunotoxin Treatment In Phase I

April 27, 2001

Treatment Doesn’t Always Follow Recommendations

February 25, 2005

In Brief: Kovac, Bunn Lead AACI; Hollings Researcher Wins Immunology Award; Turrisi Moves To SC

September 16, 1994